Department of Psychiatry
Penn Behavioral Health

Center for Studies of Addiction

subpage feature


Mondays at 3:00 p.m.
3900 Chestnut Street


Fall 2015

September 14
Diane Abatemarco, PhD, MSW
Research in Mindfulness Based Programs with Women Treated for Opioid Addiction Post-Partum & with Pregnant Women at Risk for Preterm Birth

September 21
Subhajit Chakravorty, MD
Alcohol and Sleep Continuity Distrubance: Newer Insights

October 5
Steven E. Lankenau, PhD
Health Conditions and Patterns of Marijuana Use among Young Adult Medical Marijuana Patients in Los Angeles

October 12
Teresea Franklin, PhD
Influence of Sex on Neural Processing Of Subliminal Cannabis Cues In Cannabis Use Disorder (CUD): Implications for Treatment Strategies

October 19
Craig A. Umscheid, MD, MSCE
Intro to Systematic Reviews and Meta-analyses

October 26
Ulf  Muller, MD
A controlled funded study of DBS for alcoholism in Germany

November 2
David Thomas, MD
NIDA Current and Future Initiatives in Pain and Addiction

November 9
Peg Calder
FAR: Why, How, and What

November 16
Andrew Strasser, PhD
Applying Human Laboratory Research to FDA Regulation of Tobacco Products

November 23
Mehmet Sofouglu, MD, PhD
Role of Progesterone in Additive Disorders: Human Laboratory and Clinical Trial Findings

November 30
Deni Carise, PhD
Developing De Novo Substance Abuse Treatment Programs – Zoning, Stigma and other challenges

December 14
Hengyi Rao, PhD
Smoking to be normal: A multimodal neuroimaging study of nicotine abstinence

December 21
Janet Audrain, PhD
Using Behavioral Economics to Understand Smoking Uptake and Persistence


Spring 2015

February 2
Sara Ward, PhD
Cocaine, cannabinoids, and inflammation

February 9
David Metzger, PhD
Drug Treatment as HIV Prevention in Asia: from Harm reduction to Addiction Treatment

February 23
Hans Rollema, PhD
Varenicline (Chantix) a decade later: an update on pharmacology, efficacy, adverse events and other indication

March 2
Andrea King, PhD
If you build it, they will come: a longitudinal framework for alcohol challenge research in at-risk drinkers

March 9
Julie Blendy, PhD
Stress, alcohol and the social mouse: Functional characterization of Oprm1 SNP

March 16
Robert Gross, MD, MSCE
Impact of Hazardous Ethanol Consumption on HIV Outcomes in Botswana

March 23
Emily Falk, PhD
Neural predictors of health behavior change

March 30
Alyse Thomas, PhD
Stress promotes alcohol consumption through excitatory GABA transmission in the VTA

April 6
Irwin Lucki, PhD
Repurposing Buprenorphine for Depression and Anxiety Disorders

April 27
Victor Hesselbrock, PhD

May 4
Erika Perez, PhD and Duncan Van Nest, BS
GluK1-containing Kainate Receptor Antagonists as Potential Pharmacotherapies for Alcohol and Cocaine Dependence

May 11
Paul Lanken, MD
Efficacy of an Online Educational Module plus Debriefing to Improve Attitudes and Communication Skills Related to Patients with Substance Use


Fall 2014

September 8
Dr. Robert Schnoll, PhD 
Improving Treatments for Nicotine Dependence

September 15
Dr. Yukiko Washio, PhD
Addressing Maternal Health Issues with a Comprehensive Approach

September 22
Dr. Brenda Curtis, PhD
Using Marketing Techniques to Recruit and Retain Research Participants

September 29
Dr. Joseph Schacht, PhD
Identification of Neural Targets for Pharmacological Treatment in Alcohol Use Disorders

October 6
Dr. Amy Hart, MD
Investigating the Genetic Influences on Substance Use Disorders Using a  Genome-Wide Approach

October 13
Dr. Reagan Wetherill, PhD

October 20
Dr. Kimberly Kirby, PhD
Progress Report from the Parents' Translational Research Center

October 27
Dr. John Dani, PhD
Dopaminergic Mechanisms Contributing to the Nicotine Addiction Process

November 3
Dr. David Festinger, PhD 
Delivering HIV Risk Reduction Services in Drug Court

November 10
Dr. Neil Epperson, MD
What? You Give Progesterone to Men? The Role of Neurosteroids in Nicotine Dependence

November 17
Dr. Rebecca Ashare, PhD
From brain to behavior: The role of APOE ε4 genotype, a susceptibility allele for Alzheimer’s disease, in nicotine dependence

November 24
Dr. Kenneth Silverman, PhD 
Incentives & Health: The Application of Operant Conditioning in Health Promotion

December 1
Jeremy Mennis, PhD
Addiction and the Environment: Why Place Matters to Substance Abuse and Treatment

December 15
Dr. Kyle Kampman, MD
An Update on Topiramate for Cocaine Dependence

December 22
Dr. Heath Schmidt, PhD